Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) [Yahoo! Finance]
ProPhase Labs, Inc. (PRPH)
US:NASDAQ Investor Relations:
prophaselabs.com/investors/annual-reports
Company Research
Source: Yahoo! Finance
has released an Update Note on ProPhase Labs Inc. (NASDAQ: PRPH). The update note includes information on ProPhase's business model, services offered, industry outlook, financial results, management commentary, valuation, and risks. The update note is available below. ProPhase Labs November 2024 Update Note Highlights from the note include: Launch of Direct-to-Consumer DNA Complete and DNA Expand Genetic Testing Offerings: In Q3 FY2024, ProPhase Labs launched two significant product offerings, DNA Complete and DNA Expand , under its wholly-owned subsidiary, DNA Complete, Inc. These initiatives mark a strategic move to enhance ProPhase's presence in the direct-to-consumer (DTC) genomics market: DNA Complete offers nearly 100% genome sequencing, differentiating itself from traditional ancestry-focused DNA tests by providing detailed insights into health, wellness, and ancestry. Available in three tiers—Essential at $195, Pro at $495, and Elite at $1,495—each option offers diff
Show less
Read more
Impact Snapshot
Event Time:
PRPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPH alerts
High impacting ProPhase Labs, Inc. news events
Weekly update
A roundup of the hottest topics
PRPH
News
- ProPhase Labs, Inc. (NASDAQ: PRPH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- ProPhase Labs, Inc. (NASDAQ: PRPH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- ProPhase Labs, Inc. (NASDAQ: PRPH) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity FirmGlobeNewswire
- ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures [Yahoo! Finance]Yahoo! Finance
PRPH
Earnings
- 11/13/24 - Miss
PRPH
Sec Filings
- 2/13/25 - Form 8-K
- 1/30/25 - Form 8-K
- 1/30/25 - Form 424B5
- PRPH's page on the SEC website